BD Biosciences Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
152
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$205M
BD Biosciences General Information
Description
Developer of an analytical flow cytometer designed to improve medical discovery, diagnostics and the delivery of care. The company's platform help enhance the safety and efficiency of clinicians' care delivery process, enabling scientists to study cells in more detail to better understand health and disease.
Contact Information
Website
www.bdbiosciences.comCorporate Office
- 173 Parkland Plaza
- Ann Arbor, MI 48103
- United States
Corporate Office
- 173 Parkland Plaza
- Ann Arbor, MI 48103
- United States
BD Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 07-Feb-2011 | $205M | Completed | Generating Revenue | ||
| 6. Later Stage VC (Series E) | 12-Jul-2010 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series D) | 13-Jul-2009 | Completed | Startup | |||
| 4. Later Stage VC (Series C) | 08-Jul-2008 | Completed | Startup | |||
| 3. Early Stage VC (Series B) | 17-Apr-2007 | Completed | Startup | |||
| 2. Accelerator/Incubator | 01-Jan-2005 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2005 | Completed | Startup |
BD Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 20,958,739 | $0.000010 | $0.02 | $0.25 | $0.25 | 1x | $0.25 | 16.73% |
| Series A | 15,471,493 | $0.000010 | $0.05 | $0.39 | $0.39 | 1x | $0.31 | 15.54% |
BD Biosciences Comparisons
Industry
Financing
Details
BD Biosciences Competitors (6)
One of BD Biosciences’s 6 competitors is BioLegend, a Formerly Accelerator/Incubator backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioLegend | Formerly Accelerator/Incubator backed | San Diego, CA | ||||
| CIS Bio International | Formerly PE-Backed | Saclay, France | ||||
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| RayBiotech | Venture Capital-Backed | Peachtree Corners, GA | ||||
| Miltenyi Biotec | Private Debt Financed | Bergisch Gladbach, Germany |
BD Biosciences Signals
BD Biosciences Former Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amherst Fund | Venture Capital | Minority | ||
| Arboretum Ventures | Venture Capital | Minority | ||
| Baird Capital | PE/Buyout | Minority | ||
| Credit Suisse | Investment Bank | Minority | ||
| Eight Roads | Corporate Venture Capital | Minority |
BD Biosciences Investments & Acquisitions (2)
BD Biosciences’s most recent deal was a Merger/Acquisition with Omega Biosystems. The deal was made on 27-Feb-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Omega Biosystems | 27-Feb-2017 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Adaptive Biotechnologies | 06-May-2015 | Later Stage VC | Biotechnology |
BD Biosciences FAQs
-
When was BD Biosciences founded?
BD Biosciences was founded in 2004.
-
Where is BD Biosciences headquartered?
BD Biosciences is headquartered in Ann Arbor, MI.
-
What is the size of BD Biosciences?
BD Biosciences has 152 total employees.
-
What industry is BD Biosciences in?
BD Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is BD Biosciences a private or public company?
BD Biosciences is a Private company.
-
What is the current valuation of BD Biosciences?
The current valuation of BD Biosciences is .
-
What is BD Biosciences’s current revenue?
The current revenue for BD Biosciences is .
-
How much funding has BD Biosciences raised over time?
BD Biosciences has raised $28.2M.
-
Who are BD Biosciences’s investors?
Amherst Fund, Arboretum Ventures, Baird Capital, Credit Suisse, and Eight Roads are 5 of 14 investors who have invested in BD Biosciences.
-
Who are BD Biosciences’s competitors?
BioLegend, CIS Bio International, Abcam, RayBiotech, and Miltenyi Biotec are some of the 6 competitors of BD Biosciences.
-
When was BD Biosciences acquired?
BD Biosciences was acquired on 07-Feb-2011.
-
Who acquired BD Biosciences?
BD Biosciences was acquired by Becton, Dickinson and Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process